🔗 Permalink

Inventor profile of:

BIRGIT C. SCHULTES

City:

ARLINGTON, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-02-15

Top Assignees for applications by BIRGIT C. SCHULTES

The entities that hold a legal rights for patent applications filed by inventor SCHULTES BIRGIT C.:

AltaRex Medical Corp. 3 Edmonton, Canada
MOMENTA PHARMACEUTICALS, INC. 2 Cambridge, MA United States
Momenta Pharmaceuticals, Inc. 2 Titusville, NJ United States
Quest PharmaTech, Inc. 1 Alberta, Canada
AltaRex Medical Corp. 1 Edmonton, AB Canada
The Regents of the University of California 1 Oakland, CA United States
Quest Pharma Tech Inc. 1 Alberta, Canada
Quest Pharmatech Inc. 1 , Canada
AltaRex --Medical-- Corp. 1 Alberta, CA United States
AltaRex Medical Corp. 1 Edmonton, Alberta, Canada

Recent patent applications by SCHULTES BIRGIT C.

BIRGIT C. SCHULTES from ARLINGTON, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-15

US20240052040A1

Chemistry; metallurgy

Sialylated Glycoproteins

#2 | 2022-05-19

US20220153833A1

Chemistry; metallurgy

METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

#3 | 2020-03-19

US20200087402A1

Chemistry; metallurgy

Sialylated Glycoproteins

#4 | 2018-11-15

US20180327498A1

Chemistry; metallurgy

Sialylated glycoproteins

#5 | 2017-03-09

US20170066826A2

Chemistry; metallurgy

Compositions and methods related to engineered Fc constructs

#6 | 2016-09-08

US20160257754A1

Chemistry; metallurgy

SIALYLATED GLYCOPROTEINS

#7 | 2016-08-11

US20160229913A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

#8 | 2013-03-07

US20130058920A1

Human necessities

Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease

#9 | 2013-01-24

US20130022614A1

Chemistry; metallurgy

IgE antibodies for the treatment of cancer

#10 | 2011-10-20

US20110256124A1

Human necessities

METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE

#11 | 2011-04-21

US20110091466A1

Chemistry; metallurgy

IgE ANTIBODIES FOR THE TREATMENT OF CANCER

#12 | 2009-11-26

US20090291075A1

Chemistry; metallurgy

BINDING AGENTS AND THEIR USE IN TARGETING TUMOR CELLS

#13 | 2009-09-03

US20090220493A1

Chemistry; metallurgy

Reagents and methods for inducing an immune response to prostate specific antigen

#14 | 2008-12-18

US20080311127A1

Human necessities

Combination therapy for treating disease

#15 | 2005-12-08

US20050271649A1

Chemistry; metallurgy

Therapeutic adjuvant

#16 | 2005-11-24

US20050260208A1

Chemistry; metallurgy

Binding agents and their use in targeting tumor cells

#17 | 2005-09-15

US20050202018A1

Chemistry; metallurgy

Reagents and methods for inducing an immune response to prostate specific antigen

#18 | 2005-03-24

US20050063976A1

Chemistry; metallurgy

Combination therapy for treating disease

#19 | 2005-02-10

US20050031619A1

Chemistry; metallurgy

Therapeutic compositions that alter the immune response

InventorID:

52423 ⎘